Pentavac Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)
- Licence status
- Withdrawn: 17/07/2019
- Active substances
- Purified diphtheria toxoid ph. eur., Purified tetanus toxoid, Adsorbed purified pertussis toxoid, Adsorbed purified filamentous haemagglutinin, Inactivated Poliomyelitis Virus Ph. Eur, Inactivated type 1 poliovirus, Inactivated type 2 poliovirus, Inactivated type 3 poliovirus, Haemophilus influenzae type b, conjugate with tetanus protein
- Dosage Form
- Powder for suspension for injection
- Licence number
- PA2131/005/001
- Licence holder
- Sanofi Pasteur
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J07CA06 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 23/03/2001